Weight-loss drugs such as semaglutide are effective at tackling the biological drivers of Alzheimer’s disease, a new study ...
Morning Overview on MSN
A $2 amino acid supplement slashed Alzheimer’s brain plaque in every animal model scientists tested
A team at Kindai University in Osaka, Japan, fed ordinary L-arginine to fruit flies and mice engineered to develop ...
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and ...
Researchers at Kindai University found that the amino acid L-arginine, costing about $2 a month, reduced amyloid-beta plaques in both fruit fly and mouse Alzheimer’s models. The orally administered ...
Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...
Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to ...
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results